Refined By:
Fields of Research (FoR 2020):  420305 Health and community services

Results 1-14 of 14 (Search time: 0.016 seconds).

Select some or all of the publications and click the Endnote Export button to be provided with a RIS export file of these publications.

Publication DateTitleAuthor(s)Date Added
1Apr-2022Are market mechanisms associated with alcohol and other drug treatment outcomes?Ritter, Alison; van de Ven, Katinka ; Vuong, Thu; Chalmers, Jenny; Dobbins, Timothy; Livingston, Michael; Berends, Lynda10-May-2022
2Jan-2022A comparison of structural features and vulnerability between government and nongovernment alcohol and other drug (AOD) treatment providersvan de Ven, K ; Ritter, A; Vuong, T; Livingston, M; Berends, L; Chalmers, J; Dobbins, T29-Jul-2022
3Jan-2021The impact of the COVID-19 pandemic on the non-government alcohol and other drug sector: future implicationsvan de Ven, Katinka ; Ritter, Alison; Stirling, Robert29-Jul-2022
4Dec-2020GP Guide to harm minimisation for patients using non-prescribed anabolic-androgenic steroids (AAS) and other performance and image enhancing drugs (PIEDs)van de Ven, Katinka ; Eu, Beng; Jackson, Eva; Han, Esther; Gouda, Nicole; Simmonds, Pat; Parsons, Craig29-Jul-2022
527-Aug-2020How vulnerable is the alcohol and other drug treatment service sector?van de Ven, Katinka ; Ritter, Alison; Vuong, Thu; Livingston, Michael; Berends, Lynda; Chalmers, Jenny; Dobbins, Tim10-Jun-2021
6Feb-2020Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatmentvan de Ven, Katinka ; Ritter, Alison; Berends, Lynda; Chalmers, Jenny; Lancaster, Kari26-Apr-2022
72020Human Enhancement Drugsvan de Ven, Katinka ; Mulrooney, Kyle J D ; McVeigh, Jim19-Feb-2020
82020Steroid Madness: Has the dark side of anabolic-androgenic steroids (AAS) been over-stated?Mulrooney, Kyle J D ; van de Ven, Katinka ; McVeigh, Jim; Collins, Rick19-Feb-2020
92020Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD fieldvan de Ven, Katinka ; Ritter, Alison; Roche, Ann9-Dec-2020
1018-Dec-2019The impact of rurality on opioid-related harms: A systematic review of qualitative researchThomas, Natalie ; van de Ven, Katinka ; Mulrooney, Kyle J D 15-Jul-2020
11Feb-2019Alcohol and other drug treatment commissioning and purchasing: Is it health care or social welfare?Ritter, Alison; van de Ven, Katinka 3-Jun-2020
122019Working with people who use performance and image enhancing drugs (PIEDs): engagement workshop targeted at healthcare professionalsvan de Ven, Katinka ; de Zeeuw, Tjeerd; Wood, William; Kean, Joseph10-Jun-2021
132019Perceptions of funding and commissioning models for alcohol and other drug (AOD) treatment services in Australia: a qualitative study of service providers and policymakersvan de Ven, Katinka ; Ritter, Alison; Lancaster, Kari; Berends, Lynda; Chalmers, Jenny28-Apr-2021
142018Does workforce matter? Examining the relationship between workforce characteristics and client treatment outcomes in the alcohol and other drug fieldvan de Ven, Katinka ; Ritter, Alison; Roche, Ann27-May-2020

Credit Name
Katinka van de Ven
Full Name
van de Ven, Katinka
Variants
van de Ven, K
 
UNE Researcher ID
une-id:kvandeve
 
Position Title
Senior Lecturer in Criminology
 
 
Scopus Author ID
Web of Science profile key
16228109
Discipline
School of HASS - Sociology and Criminology
 
Faculty
Faculty of HASS and Education
Surname
van de Ven
loader Loading... 2 0 5 0 false
Given Name
Katinka
 
School/Department
School of Humanities, Arts and Social Sciences
loader Loading... 3 0 5 0 false